Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids
Open accessThe DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Taking into consideration that glucocorticoid (GC) hormones have been used clinically for over half a century and that more than 20 yr have passed since the cloning of the GC receptor (GR), it is hard to imagine that novel aspects in the molecular mechanism by which GCs mediate their antiinflammatory actions are still being unveiled today. Partly, this is because almost on a daily basis, novel insights arise from parallel fields, e.g. nuclear receptor cofactor and chromatin regulation and their concomitant impact on gene transcription events, eventually leading to a revisitation or refinement of old hypotheses. On the other hand, it does remain striking and puzzling why GCs use different mechanisms in so many different cell types and on many different target genes to elicit an antiinflammatory effect. Meanwhile, the obvious question for the clinic remains: is the separation of GR functionalities through differential ligand design the strategy of choice to avoid most GC-mediated side effects? This minireview aims to highlight some of the latest findings on aspects of the antiinflammatory working mechanisms of GCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A failure in GR function, as hypothesized to take place in depression, may therefore result from reduced glucocorticoid binding to GR, reduced GR expression, enhanced activation of inflammatory pathways, or lack of co-repressor activity”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as De Bosscher and Haegeman, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., & Evans, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90397-w · Cited by 1,221
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Cited by
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
“…2002; Elmore et al., 2004) - indeed this has recently been exploited in the search for “dissociated” ligands which dissociate the beneficial anti-inflammatory (repressive) effects of GR agonism from the unwanted metabolic (activation) effects (Schacke et al., 2007; De Bosscher and Haegeman, 2009).”
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
A General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592
“Although the inactive receptor usually resides in the cytoplasm, constant GR shuttling between the nucleus and the cytoplasm has been reported also in the absence of glucocorticoids (Savory et al., 1999; De Bosscher and Haegeman, 2009).”
BackgroundReddy, T. E., Pauli, F., Sprouse, R. O., Neff, N. F., Newberry, K. M., Garabedian, M. J., & Myers, R. M. (2009) · Genome Research · doi:10.1101/gr.097022.109 · Cited by 543
NF-κB Signaling: Multiple Angles to Target OA
B. Marcu, K., Otero, M., Olivotto, E., Maria Borzi, R., & B. Goldring, M. (2010) · Current Drug Targets · doi:10.2174/138945010791011938 · Cited by 565
“the specific receptor, the latter occurs by interfering with the recruitment of co-activators or general transcription factors to NF- B target gene promoters or also by the direct recruitment of transcriptional co-repressor complexes to NFBs bound to their target genes [176, 180-183].”
BackgroundGlucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
“A failure in GR function, as hypothesized to take place in depression, may therefore result from reduced glucocorticoid binding to GR, reduced GR expression, enhanced activation of inflammatory pathways, or lack of co-repressor activity (De Bosscher and Haegeman, 2009).”
BackgroundSurjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551
“…are given as the mean ± SEM. useful for such screenings, as well as for characterizing the mode of action of some non-GC-derived compounds that may exhibit some of the beneficial therapeutic activities of dissociated GCs, but be devoid of their detrimental effects (De Bosscher and Haegeman, 2009).”
BackgroundHistone deacetylases as regulators of inflammation and immunity
Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., & Sweet, M. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.001 · Cited by 546
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
“The details of these mechanisms are not well established for most members of the steroid receptor family but have been the focus of studies on GR actions due to their involvement in the antiinflammatory response (133, 135).”
BackgroundThe role of the glucocorticoid receptor in inflammation and immunity
Baschant, U., & Tuckermann, J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.058 · Cited by 352
Biocompatible Materials for Continuous Glucose Monitoring Devices
Nichols, S. P., Koh, A., Storm, W. L., Shin, J. H., & Schoenfisch, M. H. (2013) · Chemical Reviews · doi:10.1021/cr300387j · Cited by 347
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
“crosstalk with NF- B is shown by GR (120).”
BackgroundSelf-citationVandevyver, S., Dejager, L., Tuckermann, J., & Libert, C. (2013) · Endocrinology · doi:10.1210/en.2012-2045 · Cited by 296
“Additionally, next to transactivation (TA) of “simple” GRE motifs by GR dimers, GR can cooperate with other transcription factors as a monomeric protein to induce transcription (31, 32) to so-called “composite” elements or by a “tethering” mechanism.”
BackgroundUhlenhaut, N. H., Barish, G. D., Yu, R. T., Downes, M., Karunasiri, M., Liddle, C., Schwalie, P., Hübner, N., & Evans, R. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.013 · Cited by 265
“A many unwanted side effects of steroid treatment (such as hyperglycemia and obesity) are due to transcriptional activation (Beck et al., 2009; De Bosscher and Haegeman, 2009).”
Interaction between circadian rhythms and stress
Koch, C. E., Leinweber, B., Drengberg, B. C., Blaum, C., & Oster, H. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.09.001 · Cited by 259
“Stress induced by cat smell, immobilization stress, or tail shocks has also a more detrimental impact when repeatedly applied during the inactive phase (Cohen et al., 2015; Fonken et al., 2016; Retana-Marquez et al., 2003).”
Hartmann, K., Koenen, M., Schauer, S., Wittig-Blaich, S., Ahmad, M., Baschant, U., & Tuckermann, J. P. (2016) · Physiological Reviews · doi:10.1152/physrev.00011.2015 · Cited by 247
“Consequently, this promotes its translocation into the nucleus and subsequent binding to the corresponding DNA sequences as well as the recruitment of co-factor (co-repressor or co-activator) complexes for regulation of gene transcription (76).”
Definitions and pathophysiology of vasoplegic shock
Lambden, S., Creagh-Brown, B. C., Hunt, J., Summers, C., & Forni, L. G. (2018) · Critical Care · doi:10.1186/s13054-018-2102-1 · Cited by 248
Africander, D., Verhoog, N., & Hapgood, J. P. (2011) · Steroids · doi:10.1016/j.steroids.2011.03.001 · Cited by 241
On the Trail of the Glucocorticoid Receptor: Into the Nucleus and Back
Vandevyver, S., Dejager, L., & Libert, C. (2012) · Traffic · doi:10.1111/j.1600-0854.2011.01288.x · Cited by 219
“Upon ligand binding, GR translocates to the nucleus, where it acts either as a homodimeric transcription factor that binds to the glucocorticoid response elements (GREs) in promoter regions of GC-inducible genes or as a monomeric protein that co-operates with other transcription factors to induce transcription (7,8).”
BackgroundCoactivation of GR and NFKB alters the repertoire of their binding sites and target genes
Rao, N. A. S., McCalman, M. T., Moulos, P., Francoijs, K.-J., Chatziioannou, A., Kolisis, F. N., Alexis, M. N., Mitsiou, D. J., & Stunnenberg, H. G. (2011) · Genome Research · doi:10.1101/gr.118042.110 · Cited by 216
“Using single-gene approaches, several modes of action for GC’s anti-inflammatory properties have been proposed (Necela and Cidlowski 2004; De Bosscher and Haegeman 2009; Coutinho and Chapman 2010).”
BackgroundSesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide
Orofino Kreuger, M. R., Grootjans, S., Biavatti, M. W., Vandenabeele, P., & D’Herde, K. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328356cad9 · Cited by 206
Clustering gene expression time series data using an infinite Gaussian process mixture model
McDowell, I. C., Manandhar, D., Vockley, C. M., Schmid, A. K., Reddy, T. E., & Engelhardt, B. E. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005896 · Cited by 193
“However, while there are a plethora of hypotheses regarding repression and a handful of well-studied cases (De Bosscher and Haegeman, 2009; Santos et al., 2011), it has proved difficult to associate repression of gene expression levels with genomic binding on a genome-wide scale (Reddy et al.,…”
BackgroundRegulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & Arzt, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00235 · Cited by 181
Kino, T., Su, Y. A., & Chrousos, G. P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0098-z · Cited by 179
“A substantial part of the effects of glucocorticoids on the immune system may be explained by the interaction between GRα with nuclear factor-κB (NF-κB), activator protein-1 (AP-1) and probably the signal transducers and activators of transcription (STATs) [27–30].”
New Insights in Glucocorticoid Receptor Signaling—More Than Just a Ligand-Binding Receptor
Scheschowitsch, K., Leite, J. A., & Assreuy, J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00016 · Cited by 152
The circadian clock and glucocorticoids – interactions across many time scales
Dickmeis, T., Weger, B. D., & Weger, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.012 · Cited by 144
“…pathway through a variety of mechanisms, including transrepression of NF-jB itself, thereby mediating part of the anti-inflammatory and immunosuppressive function of glucocorticoids (Coutinho and Chapman, 2011; De Bosscher and Haegeman, 2009; Kassel and Herrlich, 2007; Van Bogaert et al., 2010).”
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
Cronstein, B. N., & Sunkureddi, P. R. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827d8790 · Cited by 160
“Side effects associated with glucocorticoid therapy mainly arise from the ability of the steroid-activated glucocorticoid receptor to activate target genes involved in the metabolism of sugar, protein, fat, muscle, and bone via transactivation and to suppress the hypothalamic-pituitary-adrenal axis via transrepression…”
BackgroundInfluentialCharmandari, E., Chrousos, G. P., Lambrou, G. I., Pavlaki, A., Koide, H., Ng, S. S. M., & Kino, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025612 · Cited by 139
“Consistently with previous reports [18,19], the mRNA expression of these genes in EBV-transformed lymphocytes that were not in circadian synchronization responded strongly to the 5-hour treatment with 5610(27) M of hydrocortisone either positively or negatively (Figure 4A and Supplemental Figure S1A).”
ResultMinireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms
Flammer, J. R., & Rogatsky, I. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0068 · Cited by 140
“The molecular basis for GC action has been reviewed in detail (56) and can be broadly classified into the following major mechanisms.”
BackgroundPresman, D. M., Ogara, M. F., Stortz, M., Alvarez, L. D., Pooley, J. R., Schiltz, R. L., Grøntved, L., Johnson, T. A., Mittelstadt, P. R., Ashwell, J. D., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001813 · Cited by 138
“This model has been the guiding principle in the search of new compounds with dissociated glucocorticoid properties [11].”
BackgroundThe Type I Interferon Signaling Pathway Is a Target for Glucocorticoid Inhibition
Flammer, J. R., Dobrovolna, J., Kennedy, M. A., Chinenov, Y., Glass, C. K., Ivashkiv, L. B., & Rogatsky, I. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00146-10 · Cited by 136
Targeting inflammation using selective glucocorticoid receptor modulators
Bosscher, K. D., Haegeman, G., & Elewaut, D. S. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.007 · Cited by 181
Self-citationInhibition of NF-κB-dependent Transcription by MKP-1
King, E. M., Holden, N. S., Gong, W., Rider, C. F., & Newton, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028381 · Cited by 130
Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions
Paakinaho, V., Makkonen, H., Jääskeläinen, T., & Palvimo, J. J. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0443 · Cited by 122
“Mol Endocrinol, March 2010, 24(3):511–525 mend.”
BackgroundLXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice
Patel, R., Patel, M., Tsai, R., Lin, V., Bookout, A. L., Zhang, Y., Magomedova, L., Li, T., Chan, J. F., Budd, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41681 · Cited by 120
Spencer, R. L., Chun, L. E., Hartsock, M. J., & Woodruff, E. R. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.12.005 · Cited by 143
Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation
Treuter, E., & Venteclef, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.008 · Cited by 119
Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression
Muzikar, K. A., Nickols, N. G., & Dervan, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909192106 · Cited by 101
Chang, F.-M., Reyna, S. M., Granados, J. C., Wei, S., Innis‐Whitehouse, W., Maffi, S. K., Rodriguez, E., Slaga, T. J., & Short, J. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397703 · Cited by 109
Mitchell, M. C., Friedman, L. S., & McClain, C. J. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.047 · Cited by 93
“This process requires recruitment of corepressor molecules, particularly histone deacetylases-6 and -2.(16,17) Unfortunately, some patients are not candidates for glucocorticoid treatment, and others develop glucocorticoid resistance by various molecular mechanisms,(18,19) which may differ between patients.”
BackgroundAnti-inflammatory glucocorticoid drugs: reflections after 60 years
Whitehouse, M. W. (2010) · Inflammopharmacology · doi:10.1007/s10787-010-0056-2 · Cited by 104
“At least four different mechanisms can be distinguished (Goulding 1998; Buttgereit et al. 2005; Rhen and Cidlowski 2005; Barnes 2006; Kirwan and Power 2007; de Bosscher and Haegeman 2009; Spies et al. 2010).”
BackgroundMolecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture
Hachemi, Y., Rapp, A. E., Picke, A., Weidinger, G., Ignatius, A. A., & Tuckermann, J. P. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0024 · Cited by 94
Reber, L. L., Daubeuf, F., Plantinga, M., Cauwer, L. D., Gerlo, S., Waelput, W., Calenbergh, S. V., Tavernier, J. H., Haegeman, G., Lambrecht, B. N., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1004227 · Cited by 88
Self-citationBouguen, G., Langlois, A., Djouina, M., Branche, J., Koriche, D., Dewaeles, E., Mongy, A., Auwerx, J., Colombel, J.-F., Desreumaux, P., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307618 · Cited by 82
Facchinello, N., Skobo, T., Meneghetti, G., Colletti, E., Dinarello, A., Tiso, N., Costa, R., Gioacchini, G., Carnevali, O., Argenton, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04535-6 · Cited by 82
“Cross talk between GR and proin fl ammatory transcription factors normally controls the down-regulation of pro-in fl ammatory cytokines 42,43 .”
Sevilla, L. M., Latorre, V., Sanchis, A., & Pérez, P. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.281 · Cited by 77
“Depending on cellular context, GCs have been shown to inhibit or synergize with the STAT3 transcription factor in terms of its phosphorylation and binding to chromatin (Bertucci et al., 2010; De Bosscher and Haegeman, 2009; Langlais et al., 2008).”
BackgroundAyroldi, E., Macchiarulo, A., & Riccardi, C. (2014) · The FASEB Journal · doi:10.1096/fj.14-254755 · Cited by 86
“disorders; and inflammatory bowel diseases (11, 12).”
De Bosscher, K., Beck, I. M., Dejager, L., Bougarne, N., Gaigneaux, A., Chateauvieux, S., Ratman, D., Bracke, M., Tavernier, J., Vanden Berghe, W., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1367-4 · Cited by 75
Self-citationRobertson, S., Allie-Reid, F., Berghe, W. V., Visser, K., Binder, A., Africander, D., Vismer, M., De Bosscher, K., Hapgood, J., Haegeman, G., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087866 · Cited by 75
Self-citationNew insights into the novel anti-inflammatory mode of action of glucocorticoids
Ingawale, D. K., & Mandlik, S. K. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1728765 · Cited by 88
Lauber, K., Keppeler, H., Munoz, L. E., Koppe, U., Schröder, K., Yamaguchi, H., Krönke, G., Uderhardt, S., Wesselborg, S., Belka, C., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.82 · Cited by 77
“dependent induction of additional transcription factors, which subsequently drive target gene expression in trans.(19) In silico promoter analyses of the 1 kb region upstream of the transcription start site disclosed several full- and half-site GRE consensus motifs within the human MFG-E8 promoter (Figure 3a).”
BackgroundInfluentialGlucocorticoid-Induced Attenuation of the Inflammatory Response in Zebrafish
Chatzopoulou, A., Heijmans, J. P. M., Burgerhout, E., Oskam, N., Spaink, H. P., Meijer, A. H., & Schaaf, M. J. M. (2016) · Endocrinology · doi:10.1210/en.2015-2050 · Cited by 79
Association Between Cortisol, Insulin Resistance and Zinc in Obesity: a Mini-Review
Morais, J. B. S., Severo, J. S., Beserra, J. B., de Oiveira, A. R. S., Cruz, K. J. C., Melo, S. R. D. S., do Nascimento, G. V. R., de Macedo, G. F. S., & Marreiro, D. D. N. (2019) · Biological Trace Element Research · doi:10.1007/s12011-018-1629-y · Cited by 84
Crosstalk between TNF and glucocorticoid receptor signaling pathways
Bogaert, T. V., Bosscher, K. D., & Libert, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.003 · Cited by 80
“Although some GR-induced genes clearly have anti-inflammatory activities, it is generally believed that the process of transrepression has the largest anti-inflammatory impact and that GC-induced side effects rather result from transactivation [11,43].”
BackgroundGlucocorticoid Therapy and Adrenal Suppression
Nicolaides, N. C., Pavlaki, A. N., Alexandra, M. A. M., & Chrousos, G. P. (2011) · Europe PMC (PubMed Central) · Cited by 71
Corticosteroid use in neurocysticercosis
Nash, T. E., Mahanty, S., García, H. H., & The Cysticercosis Group in Peru (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.86 · Cited by 69
Transcriptional and Metabolic Effects of Glucocorticoid Receptor α and β Signaling in Zebrafish
Chatzopoulou, A., Roy, U., Meijer, A. H., Alia, A., Spaink, H. P., & Schaaf, M. J. M. (2015) · Endocrinology · doi:10.1210/en.2014-1941 · Cited by 68
Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in Mice
Van Bogaert, T., Vandevyver, S., Dejager, L., Van Hauwermeiren, F., Pinheiro, I., Petta, I., Engblom, D., Kleyman, A., Schütz, G., Tuckermann, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212365 · Cited by 64
Mechanisms of glucocorticoid action and insensitivity in airways disease
Boardman, C., Chachi, L., Gavrila, A., Keenan, C. R., Perry, M. M., Xia, Y., Meurs, H., & Sharma, P. K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.008 · Cited by 82
“Many of the anti-inflammatory effects of glucocorticoids are causedbybinding to the cGR, primarily through the classical pathway, leading to binding of activated receptors to GREs in the DNA [55].”
BackgroundInfluentialSobesky, J. L., D’Angelo, H. M., Weber, M. D., Anderson, N. D., Frank, M. G., Watkins, L. R., Maier, S. F., & Barrientos, R. M. (2016) · eNeuro · doi:10.1523/eneuro.0113-16.2016 · Cited by 77
“Classically, the immune-modulatory impacts of CORT have been viewed as primarily antiinflammatory (De Bosscher and Haegeman, 2009).”
BackgroundLoo, G., Sze, M., Bougarne, N., Praet, J., Guire, C. M., Ullrich, A., Haegeman, G., Prinz, M., Beyaert, R., & Bosscher, K. D. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0236 · Cited by 70
“nisms may account for the inhibitory activity of GCs on NF- B-driven gene expression, ranging from a loss of NF- B from the DNA but maintaining a nuclear phenotype or a loss of NF- B from the DNA coupled to the translocation of NF- B out of the nucleus, to an interference mechanism between the activated GR and NF- B w…”
BackgroundInfluentialSelf-citationIt takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions
Nixon, M., Andrew, R., & Chapman, K. E. (2012) · Steroids · doi:10.1016/j.steroids.2012.09.013 · Cited by 74
Geiss, A., Rohleder, N., & Anton, F. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.021 · Cited by 73
Haas, M. J., & Mooradian, A. D. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1057 · Cited by 65
Photostability of Topical Agents Applied to the Skin: A Review
Kryczyk-Poprawa, A., Kwiecień, A., & Opoka, W. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010010 · Cited by 58
Ugor, E., Prenek, L., Pap, R., Berta, G., Ernszt, D., Najbauer, J., Németh, P., Boldizsár, F., & Berki, T. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.010 · Cited by 247
Verhoog, N. J. D., Du Toit, A., Avenant, C., & Hapgood, J. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193672 · Cited by 56
Kfir‐Erenfeld, S., Sionov, R. V., Spokoini, R., Cohen, O., & Yefenof, E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.506570 · Cited by 61
“GC-induced gene expression in these cases may be achieved via composite GC-responsive regions, in which binding of additional transcription factors allows an efficient induction of GC-mediated gene expression [36].”
BackgroundInfluentialAdipocyte glucocorticoid receptor has a minor contribution in adipose tissue growth
Desarzens, S., & Faresse, N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0121 · Cited by 55
“The nongenomic pathway involves the direct interaction of GR with the MAPK protein JNK in the cytoplasm, suppressing the activation of this pro-inflammatory pathway (De Bosscher & Haegeman 2009).”
BackgroundMethodInfluentialHarr, M. W., Rong, Y., Bootman, M. D., Roderick, H. L., & Distelhorst, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005579 · Cited by 57
5α-Reduced glucocorticoids: a story of natural selection
Nixon, M., Upreti, R., & Andrew, R. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0318 · Cited by 69
Kanwal, Z., Zakrzewska, A., den Hertog, J., Spaink, H. P., Schaaf, M. J. M., & Meijer, A. H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200551 · Cited by 56
Cohen, H., Kozlovsky, N., Matar, M. A., Zohar, J., & Kaplan, Z. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.118 · Cited by 49
Bouguen, G., Dubuquoy, L., Desreumaux, P., Brunner, T., & Bertin, B. (2015) · Steroids · doi:10.1016/j.steroids.2014.12.022 · Cited by 57
“Consistent with the general immunoregulatory properties of GC [57,58], as well as the induction of intestinal steroidogenesis fol lowing immune activation, it is likely that local GC release is”
BackgroundExperience and the ever‐changing brain: What the transcriptome can reveal
Rubin, T. G., Gray, J. D., & McEwen, B. S. (2014) · BioEssays · doi:10.1002/bies.201400095 · Cited by 47
Glucocorticoid receptors, epidermal homeostasis and hair follicle differentiation
Pérez, P. (2011) · Dermato-Endocrinology · doi:10.4161/derm.15332 · Cited by 47
Permpoon, U., Moon, J., Kim, C. Y., & Nam, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157616 · Cited by 241
Gupta, S., & Guleria, R. S. (2022) · Cells · doi:10.3390/cells11132034 · Cited by 50
Cross Talk between Glucocorticoid and Estrogen Receptors Occurs at a Subset of Proinflammatory Genes
Čvoro, A., Yuan, C., Paruthiyil, S., Miller, O. H., Yamamoto, K. R., & Leitman, D. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002205 · Cited by 52
“kB after it binds to the promoter of target genes by different mechanisms depending on the gene (5, 6).”
BackgroundOn the retinal toxicity of intraocular glucocorticoids
Torriglia, A., Valamanesh, F., & Béhar‐Cohen, F. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.012 · Cited by 49
“They are also administered topically to the skin, nose or lungs [1].”
Silva, E. J. R., Queiróz, D. B. C., Honda, L., & Avellar, M. C. W. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.013 · Cited by 47
The zebrafish as an in vivo model system for glucocorticoid resistance
Schoonheim, P. J., Chatzopoulou, A., & Schaaf, M. J. M. (2010) · Steroids · doi:10.1016/j.steroids.2010.05.010 · Cited by 50
Wang, M., Ramírez, J. A., Han, J., Jia, Y., Domenico, J. M., Seibold, M. A., Hagman, J. R., & Gelfand, E. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.027 · Cited by 42
Rollins, D. A., Kharlyngdoh, J. B., Coppo, M., Tharmalingam, B., Mimouna, S., Guo, Z., Sacta, M. A., Pufall, M. A., Fisher, R. P., Hu, X., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01569-2 · Cited by 46
Liang, H., Kowalczyk, P., Junco, J. J., Santiago, H. L. P. K.-D., Malik, G., Wei, S., & Slaga, T. J. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22029 · Cited by 46
Mooij, C. F., Kroese, J. M., Sweep, F. C. G. J., Hermus, A. R. M. M., & Tack, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024204 · Cited by 42
“It is well known that glucocorticoids have antiinflammatory effects, but data on the direct effect of glucocorticoid treatment on CRP levels are lacking.[20]”
BackgroundSanchez, N. C. B., Carroll, J. A., Randel, R. D., Willard, S. T., VANN, R. C., Chase, C. C., Lawhon, S. D., Hulbert, L. E., & Welsh, T. H. (2011) · Livestock Science · doi:10.1016/j.livsci.2011.01.013 · Cited by 50
Nuclear receptors in the cross-talk of drug metabolism and inflammation
Gerbal‐Chaloin, S., Iankova, I., Maurel, P., & Daujat‐Chavanieu, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.756011 · Cited by 46
“Moreover, the expression of SRC-1, PGC-1α, and PGC-1β (PPAR coactivator 1α/β) coactivators was also reduced in response to TNF-α and IL-1β in liver cells (De Bosscher and Haegeman, 2009).”
BackgroundReduced Glucocorticoid Receptor Protein Expression in Children with Critical Illness
Indyk, J. A., Candido-Vitto, C., Wolf, I. M., Venkataraman, S., Munoz, R., Saladino, R. A., Witchel, S. F., & DeFranco, D. B. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348290 · Cited by 41
Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?
Moortel, L. V., Gevaert, K., & Bosscher, K. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.559673 · Cited by 46
Martínez‐García, M. Á., Oscullo, G., García‐Ortega, A., Matera, M. G., Rogliani, P., & Cazzola, M. (2022) · Drugs · doi:10.1007/s40265-022-01785-1 · Cited by 42
“The clinical effectiveness of synthetic exogenous corticosteroids as anti-inflammatory drugs is mostly related to their capacity to inhibit the expression of pro-inflammatory genes through activating the glucocorticoid receptor (GR), and, concurrently, they decrease the activity of pro-inflammatory transcription facto…”
BackgroundZhang, J., Ge, P., Liu, J., Luo, Y., Guo, H., Zhang, G., Xu, C., & Chen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512138 · Cited by 47
Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells
Price, L., Shao, D., Meng, C., Perros, F., Garfield, B. E., Zhu, J., Montani, D., Dorfmüller, P., Humbert, M. J. C., Adcock, I. M., et al. (2015) · Respiratory Research · doi:10.1186/s12931-015-0262-y · Cited by 39
“As such we sought to investigate the mechanisms by which GCs reverse remodelling in the MCT model of PH. Understanding such mechanisms may provide novel and more effective treatments for the future.”
BackgroundActivated glucocorticoid and eicosanoid pathways in endometriosis
Monsivais, D., Bray, J. D., Su, E., Pavone, M. E., Dyson, M. T., Navarro, A., Kakinuma, T., & Bulun, S. E. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.030 · Cited by 37
“Glucocorticoids exert this effect via the glucocorticoid receptor (GR), which upon binding of its ligand, represses DNA-binding factors that are involved in pro-inflammatory responses (30).”
BackgroundTiwari, M., Oasa, S., Yamamoto, J., Mikuni, S., & Kinjo, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-04499-7 · Cited by 37
Keratinocyte-Targeted Overexpression of the Glucocorticoid Receptor Delays Cutaneous Wound Healing
Sanchis, A., Alba, L., Latorre, V., Sevilla, L. M., & Pérez, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029701 · Cited by 35
“Glucocorticoid (GC) derivatives are widely used as therapeutic agents in acute and chronic inflammatory diseases due to their anti-inflammatory properties [1].”
Backgroundvan Lierop, M.-J. C., Alkema, W. B. L., Laskewitz, A. J., Dijkema, R., van der Maaden, H. M., Smit, M. J., Plate, R., Conti, P. G. M., Jans, C. G. J. M., Timmers, C. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048385 · Cited by 39
“, NFkB and AP-1 [4,5].”
Toit, R. L.-D., Hapgood, J. P., & Africander, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587311 · Cited by 45
“For IL-10, we investigated the binding sites such as STAT-3 and activator protein (AP)-1, as tethering of the GR to STAT-3 and AP-1 has previously been associated with suppression of some genes (68, 69).”
BackgroundSevilla, L. M., Bayo, P., Latorre, V., Sanchís, A., & Pérez, P. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0183 · Cited by 42
Metadata
- Authors
- De Bosscher, K., & Haegeman, G.
- Affiliations
- Laboratory of Eukaryotic Gene Expression and Signal Transduction, Department of Physiology, Ghent University, 9000 Gent, Belgium
- Ghent University (BE)
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-03-01
- Volume
- 23
- Issue
- 3
- Pages
- 281-291
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC5428155
- OpenAlex
- W2092900546
- Cited by
- 284
- References
- 133
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 2 · 2023: 14 · 2022: 13 · 2021: 6 · 2020: 8 · 2019: 10 · 2018: 11 · 2017: 17 · 2016: 15 · 2015: 15 · 2014: 20 · 2013: 30 · 2012: 22
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Universiteit Gent
- Vlaamse regering
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoids, anti-inflammatory mechanism, glucocorticoid receptor, nuclear receptor cofactors, chromatin regulation, gene transcription, glucocorticoid adverse effects, cell type-specific gene regulation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Gene Expression Regulation, Glucocorticoids, Humans, Immunosuppressive Agents, Models, Biological, Receptors, Glucocorticoid, Repressor Proteins, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.